Although TAZ and YAP have been acknowledged as central oncoproteins in multiple cancers including breast, colon, liver, lung, pancreatic, and thyroid cancers [33], the dominant paradigm is that these two oncoproteins are activated relatively late in tumor progression. Here, YAP1 is linked to thyroid cancer.